DK154749C - Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur - Google Patents

Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur

Info

Publication number
DK154749C
DK154749C DK212580A DK212580A DK154749C DK 154749 C DK154749 C DK 154749C DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 154749 C DK154749 C DK 154749C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
cell culture
influenza virus
virus vaccine
Prior art date
Application number
DK212580A
Other languages
Danish (da)
English (en)
Other versions
DK212580A (da
DK154749B (da
Inventor
Karen K Brown
Richard C Stewart
Original Assignee
Mobay Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK154749(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mobay Corp filed Critical Mobay Corp
Publication of DK212580A publication Critical patent/DK212580A/da
Publication of DK154749B publication Critical patent/DK154749B/da
Application granted granted Critical
Publication of DK154749C publication Critical patent/DK154749C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK212580A 1979-05-15 1980-05-14 Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur DK154749C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15
US3923679 1979-05-15

Publications (3)

Publication Number Publication Date
DK212580A DK212580A (da) 1980-11-16
DK154749B DK154749B (da) 1988-12-19
DK154749C true DK154749C (da) 1989-05-16

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK212580A DK154749C (da) 1979-05-15 1980-05-14 Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur

Country Status (13)

Country Link
EP (1) EP0019218B2 (ja)
JP (1) JPS55153723A (ja)
AR (1) AR220838A1 (ja)
AT (1) ATE16454T1 (ja)
AU (1) AU535804B2 (ja)
CA (1) CA1122527A (ja)
DE (1) DE3071225D1 (ja)
DK (1) DK154749C (ja)
ES (1) ES8104405A1 (ja)
IL (1) IL60063A0 (ja)
NO (1) NO801443L (ja)
RO (1) RO79525B (ja)
YU (1) YU41923B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
DE69535940D1 (de) * 1994-11-10 2009-06-04 Baxter Healthcare Sa Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur
JPH11509081A (ja) * 1994-11-16 1999-08-17 セント ジュード チルドレンズ リサーチ ホスピタル 新規の複製プロセス
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
EP2923711A1 (en) 2004-11-03 2015-09-30 Novartis Vaccines and Diagnostics, Inc. Influenza vaccination
EP2022849A4 (en) * 2006-05-11 2010-10-06 Chemo Sero Therapeut Res Inst METHOD FOR PROLIFERATION OF INFLUENZA VIRUS
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EA201500910A1 (ru) 2009-02-10 2016-04-29 Новартис Аг Вакцины против гриппа со сниженным количеством сквалена

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (ja) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
YU126580A (en) 1983-12-31
IL60063A0 (en) 1980-07-31
RO79525A (ro) 1984-07-17
ES491517A0 (es) 1981-04-01
NO801443L (no) 1980-11-17
DK212580A (da) 1980-11-16
YU41923B (en) 1988-02-29
EP0019218B2 (de) 1995-03-01
CA1122527A (en) 1982-04-27
RO79525B (ro) 1984-09-30
EP0019218A3 (en) 1981-03-25
DK154749B (da) 1988-12-19
JPS55153723A (en) 1980-11-29
DE3071225D1 (en) 1985-12-19
ATE16454T1 (de) 1985-11-15
JPH0124769B2 (ja) 1989-05-15
AR220838A1 (es) 1980-11-28
AU5824480A (en) 1980-11-20
EP0019218B1 (de) 1985-11-13
ES8104405A1 (es) 1981-04-01
EP0019218A2 (de) 1980-11-26
AU535804B2 (en) 1984-04-05

Similar Documents

Publication Publication Date Title
DK154539C (da) Fremgangsmaade til fremstilling af cyclosporinholdige farmaceutiske praeparater i flydende form
DK149942C (da) Fremgangsmaade til fremstilling af en pasteurellose-vaccine
DK154749C (da) Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur
DK223976A (da) Fremgangsmade til dyrkning af celler
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK159100C (da) Fremgangsmaade til fremstilling af en flydende viral vaccine indeholdende en stabilisator og stabilisator, der kan benyttes i en saadan fremgangsmaade
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK409780A (da) Fremgangsmaade til fremstilling af peptider
DK155915C (da) Fremgangsmaade til fremstilling af pertussis-toksoid til anvendelse i vacciner
DK455679A (da) Fremgangsmaade til fremstilling af rekombinat dna.
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK580378A (da) Ark med hoejt indhold af fyldstof og fremgangsmaade til deres fremstilling
DK148981C (da) Fremgangsmaade til fremstilling af et immobiliseret enzympraeparat
DK143477A (da) Fremgangsmade til dyrkning af celler
DK289378A (da) Fremgangsmaade til dyrkning af virus
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK517979A (da) Fremgangsmaade til fremstilling af alkohol
DK307080A (da) Fremgangsmaade til fremstilling af en ny polyvalent virusvaccine
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK569078A (da) Fremgangsmaade til fremstilling af nye arylaminoimidazolinderivater

Legal Events

Date Code Title Description
PUP Patent expired